Scientists from the Institute of Chemistry of the Siberian Branch of the Russian Academy of Sciences have obtained compounds that work against Parkinson's disease.
Anna Salnikova News Feed Editor
Scientists from the Novosibirsk Institute of Organic Chemistry named after Vorozhtsov of the Siberian Branch of the Russian Academy of Sciences have obtained promising compounds based on derivatives of the drug "Prottremin," which have shown activity against Parkinson's disease, reports TASS. "Prottremin" was developed at the same institute. In 2022, it was reported that the drug successfully passed preclinical studies and the first phase of clinical trials.
According to the patent reviewed by the agency, previous attempts to modify the drug's structure often led to a decrease or loss of activity. Therefore, it was important for scientists to find modifications that would either preserve or enhance the action of the substance. The document states that all obtained compounds demonstrate antiparkinsonian activity. Moreover, its intensity depends on the chosen disease model and type of motor test.
Researchers managed not only to preserve the desired properties of "Prottremin" derivatives but also to increase the effectiveness of individual compounds. As a result of the tests, their action was found to be comparable to or exceeded that of the original drug. Additionally, some compounds showed results surpassing the effect of "Levodopa." In the patent, this drug is referred to as the "gold standard" for Parkinson's disease therapy.
The tests were conducted on mice, in which Parkinson's disease was artificially induced using a special toxin. Two out of three obtained substances improved the animals' motor activity, while the third positively affected their coordination during the test.
Parkinson's disease is a progressive neurodegenerative disease of the central nervous system. It leads to the death of nerve cells that produce dopamine—a neurotransmitter involved in the regulation of movements, mood, and cognitive functions.
According to the World Health Organization's forecast, by 2050, the number of people with Parkinson's disease worldwide may exceed 12 million.
We also recommend: Love suffers defeat, money brings luck: three zodiac signs that fate will reveal secret financial opportunities The heavens will intervene in life: who will receive the protection of an Angel and fateful gifts starting May 15 Driver's licenses are at risk in 2027: all the details about new rules, sanctions, and unexpected restrictions for motorists Fried eggs and porridge fade into the background: a pancake made of 2 eggs and oatmeal replaces breakfast, satisfies, and saves time The "Fat-Burning" salad works wonders for dinner: the belly disappears in a month, burning fat faster than any "Brushes"
More news about the event:
Scientists from the Siberian Branch of the Russian Academy of Sciences have obtained compounds that work against Parkinson's disease
Anna Salnikova News Feed Editor
Scientists from the Novosibirsk Institute of Organic Chemistry named after Vorozhtsov of the Siberian Branch of the Russian Academy of Sciences have obtained promising compounds based on derivatives of the drug "Prottremin,"09:35 15.05.2026 ProKazan.Ru - Kazan
In Russia, compounds have been created that fight against Parkinson's disease
Anna Salnikova News Feed Editor
Scientists from the Institute of Organic Chemistry named after N.N.09:35 15.05.2026 ProKazan.Ru - Kazan
News from neighboring regions on the topic:
In Russia, compounds have been obtained that fight against Parkinson's disease
Aнастасия Федосеева Chief Editor
Photo: freepik
Scientists from the Institute of Organic Chemistry named after N.N.08:36 15.05.2026 ProGorodSamara.Ru - Samara
Другие Новости Казани (Казань716)
Scientists from the Institute of Chemistry of the Siberian Branch of the Russian Academy of Sciences have obtained compounds that work against Parkinson's disease.
Anna Salnikova News Feed Editor Scientists from the Novosibirsk Institute of Organic Chemistry named after Vorozhtsov of the Siberian Branch of the Russian Academy of Sciences have obtained promising compounds based on derivatives of the drug "Prottremin," 15.05.2026. ProKazan.Ru. Republic of Tatarstan. Kazan.
